Equities

ADM Tronics Unlimited Inc

ADMT:QBB

ADM Tronics Unlimited Inc

Actions
  • Price (USD)0.0792
  • Today's Change0.00 / 0.00%
  • Shares traded93.00
  • 1 Year change-45.19%
  • Beta0.0194
Data delayed at least 15 minutes, as of Jul 23 2024 15:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ADM Tronics Unlimited, Inc. is a technology-based developer and manufacturer of diversified lines of products and services in various areas, including electronics for non-invasive medical and other applications; research, development, regulatory and engineering services; and environmentally safe chemical products for industrial, cosmetic, and topical uses. The Company operates in three segments: Chemical, Electronics and Engineering. It offers a range of engineering services, including research, development, quality control and quality assurance services along with regulatory compliance services. The Company has developed several medical and cosmetic topical products. Its water-based, adhesive, and related topical formulations are used for maxillofacial prosthetic medical applications and for professional makeup applications primarily for special makeup effects for film, television, and theatrical productions. The Company's wholly owned subsidiary is Sonotron Medical Systems, Inc.

  • Revenue in USD (TTM)2.97m
  • Net income in USD-877.23k
  • Incorporated1969
  • Employees7.00
  • Location
    ADM Tronics Unlimited Inc224 S Pegasus AveNORTHVALE 07647United StatesUSA
  • Phone+1 (201) 767-6040
  • Fax+1 (201) 784-0620
  • Websitehttps://www.admtronics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Venus Concept Inc73.30m-37.39m4.07m304.00------0.0555-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
Encision Inc6.59m-691.78k4.27m22.00--2.34--0.6489-0.0588-0.05880.55950.1541.662.097.27299,357.70-17.41-3.03-24.73-4.1347.6251.25-10.50-1.890.8393-10.270.1272---10.38-5.64-113.55---9.54--
Dror Ortho-Design Inc0.00-4.83m4.46m4.00--1.87-----0.0115-0.01150.000.00480.00-------357.10-140.50-595.21---------118,188.00----0.00-------1,896.02------
Sharps Technology Inc0.00-8.71m4.54m3.00--0.6615-----0.6204-0.62040.000.43780.00-------74.67---95.84----------0.492--0.00-------112.12------
Reflect Scientific Inc1.27m-343.17k4.67m7.00--2.51--3.68-0.004-0.0040.01480.02170.51290.61845.72181,111.40-13.8811.10-16.4313.2156.0662.48-27.0710.002.21--0.00---47.09-6.99-613.46------
ReShape Lifesciences Inc8.34m-10.92m4.73m31.00--1.04--0.5674-2.30-2.300.73190.19330.67810.81784.52268,871.00-88.83-136.06-162.20-194.3265.8556.30-130.99-408.361.26--0.00---22.79-0.947475.36---49.29--
Nu-Med Plus Inc0.00-119.16k4.75m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
Aethlon Medical, Inc.0.00-12.21m5.11m14.00--0.1676-----4.87-4.870.002.190.00----0.00-94.80-76.25-108.90-85.78-------2,246.87----0.00---100.00---1.43------
Caduceus Software Systems Corp0.00-117.60k5.35m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
ADM Tronics Unlimited Inc2.97m-877.23k5.35m7.00--7.73--1.81-0.013-0.0130.04390.01021.134.897.04---33.56-15.22-58.66-22.0937.6541.15-29.58-18.580.8015-316.560.4233---19.35-0.3572-810.74------
Sonendo Inc40.19m-57.74m5.39m216.00--0.2197--0.1341-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Predictive Oncology Inc1.96m-14.78m5.66m34.00--1.38--2.89-3.66-3.660.48530.99770.10991.714.9557,642.65-82.89-91.80-108.54-126.2964.1864.64-754.19-1,419.991.35--0.0093--18.244.7545.67--5.44--
Biomerica Inc5.41m-6.35m5.84m62.00--0.748--1.08-0.3789-0.37890.32240.46420.58272.285.7487,180.80-68.45-43.55-83.73-50.3211.4115.75-117.46-55.863.37--0.00---71.71-0.8229-57.58---9.76--
ALR Technologies Inc9.49k-8.00m6.35m6.00------669.62-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Sigyn Therapeutics Inc0.00-3.56m6.43m5.00---------3.04-3.040.00-3.280.00----0.00-724.37-493.15-----------10,223.960.0199-1.92---------41.51------
BioSig Technologies Inc27.00k-25.25m6.49m4.00------240.28-3.24-3.240.0033-0.37760.008--1.746,750.00-728.65-269.73---363.1148.15---91,566.66-24,485.73---------93.71---6.52---9.58--
Data as of Jul 23 2024. Currency figures normalised to ADM Tronics Unlimited Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.